CRISPR therapy saves infant with rare metabolic disorder
CRISPR-based gene editing therapy has been used for the first time to treat CPS1 deficiency, which promises a new era for precision medicine.
Issue 1872
22nd May 2025
CRISPR-based gene editing therapy has been used for the first time to treat CPS1 deficiency, which promises a new era for precision medicine.
Trends in language learning at Imperial (and beyond).
A focus on stopping rising inequality is the economic and cultural innovation needed to fight climate change.